Compare Cardinal Health Inc (CAH) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cardinal Health Inc vs BIO-TECHNE Corp — how do they compare? Cardinal Health Inc trades at $229 (market cap $54.72B), while BIO-TECHNE Corp trades at $71.23 (market cap $11.12B). The key difference: Cardinal Health Inc is far larger — about 4.9× BIO-TECHNE Corp's market cap, and Cardinal Health Inc pays the higher dividend (0.88%). Which is the better fit depends on your goals.
| CAH | TECH | |
|---|---|---|
Market Cap | $54.72B | $11.12B |
Sector | Health | Health |
52-Week High | $239.71 | $71.38 |
52-Week Low | $146.04 | $43.31 |
Enterprise Value | $59.70B | $11.20B |
Dividend Yield | 0.88% | 0.45% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
